Twist Bioscience Is Bent, Not Broken: Near-Term Strain, Long-Term Strength

Group 1 - Twist Bioscience's revenue growth is moderating due to macro headwinds and temporary factors affecting growth [1] - Narweena, an asset manager, focuses on identifying market dislocations and businesses with long-term growth opportunities [1] - The investment strategy emphasizes smaller cap stocks and markets with less obvious competitive advantages [1] Group 2 - An aging population and low population growth are expected to create new investment opportunities, contrasting with past trends [1] - Many industries may experience stagnation or secular decline, potentially improving business performance due to reduced competition [1] - The economy is increasingly dominated by asset-light businesses, leading to a decline in infrastructure investment needs [1]